Anfernee Jennings

Edge Rusher

Age: 23
Free Agency: 2024 (UFA)
Accrued Seasons: 0
  • 2020 Salary Cap Charge: $835,795 (0.40% of cap)
  • 2020 Cash Payout: $1,513,180 (1.02% of spending)
  • 2020 Cash to Cap Ratio: 1.81
  • Contract Value: $4,503,929 ($1,125,982 APY)
  • Fully Guaranteed Money: $903,180
  • Contract Ranking: 87/204 at EDGE

Current Contract

(Drafted, signed 2020)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusCap
Cap %
Dead Money & Cap Savings

Contract Notes

Anfernee Jennings signed a four year, $4.504 million contract with the Patriots on May 7, 2020. Jennings signing bonus is worth $903,180.
Career Earnings: $903,180
Career APY: $0
Potential Earnings: $4,503,929
Total Guarantees: $903,180
Largest Cash Payment: $1,513,180 (2020)
Largest Cap Number: $1,390,195 (2023)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money


YearGames PlayedGames MissedSnapsTacklesNegative PlaysInterceptionsFumblesTD
InjuredHealthyDefenseSpecialSoloAssistSacksYardsTFLQB HitsPass Def.INTYardsForcedRec.Yards

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Injury Adjusted$786,000$1,125,982
OTC Valuation $4.5M $8.9M $13.4M $17.8M $22.3M APY $3.9M $7.8M $11.8M $15.7M $19.6M $5,928,000 $7,038,596

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.